Supp Table 1 from Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912)
Authors:
- Jennifer H. FosterJFJennifer H. Foster
- Stephan D. VossSVStephan D. Voss
- David C. HallDHDavid C. Hall
- Charles G. MinardCMCharles G. Minard
- Frank M. BalisFBFrank M. Balis
- Keith WilnerKWKeith Wilner
- Stacey L. BergSBStacey L. Berg
- Elizabeth FoxEFElizabeth Fox
- Peter C. AdamsonPAPeter C. Adamson
- Susan M. BlaneySBSusan M. Blaney
- Brenda J. WeigelBWBrenda J. Weigel
- Yael P. MosséYMYael P. Mossé
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)